Med BioGene Inc. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced net loss was USD 54,542 compared to USD 63,475 a year ago. Basic eps - continuing operations was USD 0 compared to basic loss per share from continuing operations of USD 0.01 a year ago.